计算溶液所需的质量、体积或浓度。
| 活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
|---|
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| Ab121566-10μl |
10μl |
现货 ![]() |
| |
| Ab121566-50μl |
50μL |
现货 ![]() |
| |
| Ab121566-100μl |
100μL |
期货 ![]() |
| |
| Ab121566-1ml |
1ml |
期货 ![]() |
|
| 产品名称 | Recombinant PHD2/prolyl hydroxylase Antibody |
|---|---|
| 别名 | Egl9同源物1(EGLN1)抗体 | PHD2/prolyl hydroxylase抗体 | 重组PHD2/脯氨酰羟化酶抗体 |
| 英文别名 | C1orf12 | EC 1.14.11.29 | EC:1.14.11.291 | ECYT3 | egl nine homolog 1 | egl nine-like protein 1 | EGLN1 | HALAH | HIF prolyl hydroxylase 2 | HIFPH2 | HIF-PH2 | HIF-prolyl hydroxylase 2 | HPH2 | HPH-2 | Hypoxia-inducible factor prolyl hydroxylase 2 | PHD2 |
| 规格或纯度 | ExactAb™, Validated, 重组, 0.6 mg/mL |
| 生化机理 | Catalyzes the post-translational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins. Hydroxylates HIF-1 alpha at 'Pro-402' and 'Pro-564', and HIF-2 alpha. Functions as a cellular oxygen sensor and, under normoxic conditions, targets HIF through the hydroxylation for proteasomal degradation via the von Hippel-Lindau ubiquitination complex. |
| 宿主种属 | 兔(Rabbit) |
| 特异性 | PHD2/prolyl hydroxylase |
| 种属反应性 | 人(Human),小鼠(Mouse) |
| 免疫原 | A synthetic peptide derived from human PHD2/prolyl hydroxylase (AA 1-51) |
| 阳性对照 | WB: Mouse kidney lysates. |
| 偶联 | Unconjugated |
| 克隆类型 | 重组抗体 |
|---|---|
| Format | Whole IgG |
| 亚型 | Rabbit IgG |
| 轻链亚型 | kappa |
| SDS-PAGE | 150 kDa |
| 纯化方法 | Protein A purified |
| 物理外观 | Liquid |
| 储存缓冲液 | 10mM PBS, 150mM NaCl, 50% Glycerol, 0.05% BSA, 0.02% Sodium azide, pH 7.4 |
| 防腐剂 | 0.02% Sodium azide |
| 浓度 | 0.6 mg/mL |
| 储存温度 | -20°C储存,避免反复冻融 |
| 运输条件 | 超低温冰袋运输 |
| 稳定性与储存 | 4°C 短期储存(1-2 周)。-20°C下长期保存(24个月)。收货后建议分装。避免冷冻/解冻循环。 |
| 分子类型 | 抗体 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
Recombinant PHD2/prolyl hydroxylase Antibody (Ab121566) - Western Blot
All lanes: Recombinant PHD2/prolyl hydroxylase Antibody (Ab121566) at 1/2000 dilution
Samples: Lysates at 20 µg per lane
Secondary: Goat Anti-Rabbit IgG H&L (HRP) (Ab170144) at 1/20000 dilution
Predicted band size: 46 kDa
Observed band size: 47 kDa
Exposure time: 256.6 s
| 应用名称 | 稀释比例 |
|---|---|
| WB | 1/500-1/2000 |
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 日期 | 货号 |
|---|---|---|---|
| 分析证书 | 24-05-16 | Ab121566 | |
| 分析证书 | 24-05-16 | Ab121566 |
| 1. Rose NR, Woon EC, Tumber A, Walport LJ, Chowdhury R, Li XS, King ON, Lejeune C, Ng SS, Krojer T et al.. (2012) Plant growth regulator daminozide is a selective inhibitor of human KDM2/7 histone demethylases.. J Med Chem, 55 (14): (6639-43). [PMID:22724510] |
| 2. Semenza GL. (2001) HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus.. Cell, 107 (1): (1-3). [PMID:11595178] |
| 3. Schiller R, Scozzafava G, Tumber A, Wickens JR, Bush JT, Rai G, Lejeune C, Choi H, Yeh TL, Chan MC et al.. (2014) A cell-permeable ester derivative of the JmjC histone demethylase inhibitor IOX1.. ChemMedChem, 9 (3): (566-71). [PMID:24504543] |
| 4. Vachal P, Miao S, Pierce JM, Guiadeen D, Colandrea VJ, Wyvratt MJ, Salowe SP, Sonatore LM, Milligan JA, Hajdu R et al.. (2012) 1,3,8-Triazaspiro[4.5]decane-2,4-diones as efficacious pan-inhibitors of hypoxia-inducible factor prolyl hydroxylase 1-3 (HIF PHD1-3) for the treatment of anemia.. J Med Chem, 55 (7): (2945-59). [PMID:22364528] |
| 5. Ogoshi Y, Matsui T, Mitani I, Yokota M, Terashita M, Motoda D, Ueyama K, Hotta T, Ito T, Hase Y et al.. (2017) Discovery of JTZ-951: A HIF Prolyl Hydroxylase Inhibitor for the Treatment of Renal Anemia.. ACS Med Chem Lett, 8 (12): (1320-1325). [PMID:29259755] |
| 6. Yeh TL, Leissing TM, Abboud MI, Thinnes CC, Atasoylu O, Holt-Martyn JP, Zhang D, Tumber A, Lippl K, Lohans CT et al.. (2017) Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials.. Chem Sci, 8 (11): (7651-7668). [PMID:29435217] |
| 7. Joharapurkar AA, Pandya VB, Patel VJ, Desai RC, Jain MR. (2018) Prolyl Hydroxylase Inhibitors: A Breakthrough in the Therapy of Anemia Associated with Chronic Diseases.. J Med Chem, 61 (16): (6964-6982). [PMID:29712435] |
| 8. [. (2012-12-14) Reporter ligand NMR screening method for 2-oxoglutarate oxygenase inhibitors.. Journal of medicinal chemistry, 56 ((2)): (547-555). [PMID:23234607] |
| 9. Sharon Gauci,Andreas O Helbig,Monique Slijper,Jeroen Krijgsveld,Albert J R Heck,Shabaz Mohammed. (2009-05-06) Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.. Analytical chemistry, 81 ((11)): (4493-4501). [PMID:19413330] |
| 10. Rotili D, Tomassi S, Conte M, Benedetti R, Tortorici M, Ciossani G, Valente S, Marrocco B, Labella D, Novellino E, Mattevi A, Altucci L, Tumber A, Yapp C, King ON, Hopkinson RJ, Kawamura A, Schofield CJ, Mai A.. (2014) Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activities.. J Med Chem, 57 (1): (42-55). [PMID:24325601] [10.1021/jm4012802] |
| 11. Vasta JD, Raines RT.. (2015) Selective inhibition of prolyl 4-hydroxylases by bipyridinedicarboxylates.. Bioorg Med Chem, 23 (13): (3081-3090). [PMID:26022078] [10.1016/j.bmc.2015.05.003] |
| 12. Lei Y, Hu T, Wu X, Wu Y, Bao Q, Zhang L, Xia H, Sun H, You Q, Zhang X.. (2015) Affinity-Based Fluorescence Polarization Assay for High-Throughput Screening of Prolyl Hydroxylase 2 Inhibitors.. ACS Med Chem Lett, 6 (12): (1236-1240). [PMID:26713111] [10.1021/acsmedchemlett.5b00394] |
| 13. Ahmed S, Ayscough A, Barker GR, Canning HE, Davenport R, Downham R, Harrison D, Jenkins K, Kinsella N, Livermore DG, Wright S, Ivetac AD, Skene R, Wilkens SJ, Webster NA, Hendrick AG.. (2017) 1,2,4-Triazolo-[1,5-a]pyridine HIF Prolylhydroxylase Domain-1 (PHD-1) Inhibitors With a Novel Monodentate Binding Interaction.. J Med Chem, 60 (13): (5663-5672). [PMID:28594552] [10.1021/acs.jmedchem.7b00352] |
| 14. Hamada M, Takayama T, Shibata T, Hiratate A, Takahashi M, Yashiro M, Takayama N, Okumura-Kitajima L, Koretsune H, Kajiyama H, Naruse T, Kato S, Takano H, Kakinuma H.. (2018) Discovery of novel 2-[(4-hydroxy-6-oxo-2,3-dihydro-1H-pyridine-5-carbonyl)amino]acetic acid derivatives as HIF prolyl hydroxylase inhibitors for treatment of renal anemia.. Bioorg Med Chem Lett, 28 (10): (1725-1730). [PMID:29681433] [10.1016/j.bmcl.2018.04.039] |
| 15. Wu Y, Jiang Z, Li Z, Gu J, You Q, Zhang X.. (2018) Click Chemistry-Based Discovery of [3-Hydroxy-5-(1 H-1,2,3-triazol-4-yl)picolinoyl]glycines as Orally Active Hypoxia-Inducing Factor Prolyl Hydroxylase Inhibitors with Favorable Safety Profiles for the Treatment of Anemia.. J Med Chem, 61 (12): (5332-5349). [PMID:29856623] [10.1021/acs.jmedchem.8b00549] |
| 16. Li Z, Su K, Jiang Z, Yu Y, You Q, Zhang X.. (2019) Photoactivatable Prolyl Hydroxylase 2 Inhibitors for Stabilizing the Hypoxia-Inducible Factor with Light.. J Med Chem, 62 (16): (7583-7588). [PMID:31244107] [10.1021/acs.jmedchem.9b00688] |
| 17. Holt-Martyn JP, Tumber A, Rahman MZ, Lippl K, Figg W, Figg W, McDonough MA, Chowdhury R, Schofield CJ.. (2019) Studies on spiro[4.5]decanone prolyl hydroxylase domain inhibitors.. Medchemcomm, 10 (4): (500-504). [PMID:31057728] [10.1039/C8MD00548F] |
| 18. Zhang X,Lei Y,Hu T,Wu Y,Li Z,Jiang Z,Yang C,Zhang L,You Q. (2020) Discovery of Clinical Candidate (5-(3-(4-Chlorophenoxy)prop-1-yn-1-yl)-3-hydroxypicolinoyl)glycine, an Orally Bioavailable Prolyl Hydroxylase Inhibitor for the Treatment of Anemia.. J Med Chem, 63 (17.0): (10045-10060). [PMID:32787144] [10.1021/acs.jmedchem.0c01161] |
| 19. Debenham JS,Madsen-Duggan C,Clements MJ,Walsh TF,Kuethe JT,Reibarkh M,Salowe SP,Sonatore LM,Hajdu R,Milligan JA,Visco DM,Zhou D,Lingham RB,Stickens D,DeMartino JA,Tong X,Wolff M,Pang J,Miller RR,Sherer EC,Hale JJ. (2016) Discovery of N-[Bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an Orally Active Pan-Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase 1-3 (HIF PHD1-3) for the Treatment of Anemia.. J Med Chem, 59 (24.0): (11039-11049). [PMID:28002958] [10.1021/acs.jmedchem.6b01242] |
| 20. Dupuy, D D and 7 more authors.. (2000) Mapping, characterization, and expression analysis of the SM-20 human homologue, c1orf12, and identification of a novel related gene, SCAND2.. Genomics, (1): [PMID:11056053] |
| 21. and Taylor, M S MS.. (2001) Characterization and comparative analysis of the EGLN gene family.. Gene, (5): [PMID:11574160] |
| 22. Epstein, A C AC and 19 more authors.. (2001) C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.. Cell, (5): [PMID:11595184] |
| 23. Oehme, Felix F and 7 more authors.. (2002) Overexpression of PH-4, a novel putative proline 4-hydroxylase, modulates activity of hypoxia-inducible transcription factors.. Biochemical and biophysical research communications, (16): [PMID:12163023] |
| 24. Ivan, Mircea M and 10 more authors.. (2002) Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor.. Proceedings of the National Academy of Sciences of the United States of America, (15): [PMID:12351678] |
| 25. Metzen, Eric E and 11 more authors.. (2003) Intracellular localisation of human HIF-1 alpha hydroxylases: implications for oxygen sensing.. Journal of cell science, (1): [PMID:12615973] |
| 26. Cioffi, Catherine L CL, Liu, Xiao Qin XQ, Kosinski, Penelope A PA, Garay, Michelle M and Bowen, Benjamin R BR.. (2003) Differential regulation of HIF-1 alpha prolyl-4-hydroxylase genes by hypoxia in human cardiovascular cells.. Biochemical and biophysical research communications, (11): [PMID:12670503] |
| 27. Hirsilä, Maija M, Koivunen, Peppi P, Günzler, Volkmar V, Kivirikko, Kari I KI and Myllyharju, Johanna J.. (2003) Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor.. The Journal of biological chemistry, (15): [PMID:12788921] |
| 28. Appelhoff, Rebecca J RJ and 7 more authors.. (2004) Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor.. The Journal of biological chemistry, (10): [PMID:15247232] |
| 29. Ozer, Abdullah A, Wu, Leeju C LC and Bruick, Richard K RK.. (2005) The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF).. Proceedings of the National Academy of Sciences of the United States of America, (24): [PMID:15897452] |
| 30. Percy, Melanie J MJ and 7 more authors.. (2006) A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis.. Proceedings of the National Academy of Sciences of the United States of America, (17): [PMID:16407130] |
| 31. Davidson, Todd L TL, Chen, Haobin H, Di Toro, Dominic M DM, D'Angelo, Gisela G and Costa, Max M.. (2006) Soluble nickel inhibits HIF-prolyl-hydroxylases creating persistent hypoxic signaling in A549 cells.. Molecular carcinogenesis, [PMID:16649251] |
| 32. Gregory, S G SG and 178 more authors.. (2006) The DNA sequence and biological annotation of human chromosome 1.. Nature, (18): [PMID:16710414] |
| 33. McDonough, Michael A MA and 16 more authors.. (2006) Cellular oxygen sensing: Crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2).. Proceedings of the National Academy of Sciences of the United States of America, (27): [PMID:16782814] |
| 34. Percy, Melanie J MJ and 5 more authors.. (2007) A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove.. Blood, (15): [PMID:17579185] |
| 35. Furlow, Paul W PW and 7 more authors.. (2009) Erythrocytosis-associated HIF-2alpha mutations demonstrate a critical role for residues C-terminal to the hydroxylacceptor proline.. The Journal of biological chemistry, (3): [PMID:19208626] |
| 36. Yasumoto, Ken-ichi K, Kowata, Yusuke Y, Yoshida, Atsushi A, Torii, Satoru S and Sogawa, Kazuhiro K.. (2009) Role of the intracellular localization of HIF-prolyl hydroxylases.. Biochimica et biophysica acta, [PMID:19339211] |
| 37. Chowdhury, Rasheduzzaman R and 7 more authors.. (2009) Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases.. Structure (London, England : 1993), (15): [PMID:19604478] |
| 38. Steinhoff, Amrei A and 6 more authors.. (2009) Cellular oxygen sensing: Importins and exportins are mediators of intracellular localisation of prolyl-4-hydroxylases PHD1 and PHD2.. Biochemical and biophysical research communications, (2): [PMID:19631610] |
| 39. Simonson, Tatum S TS and 11 more authors.. (2010) Genetic evidence for high-altitude adaptation in Tibet.. Science (New York, N.Y.), (2): [PMID:20466884] |
| 40. Bigham, Abigail and 13 more authors.. (2010) Identifying signatures of natural selection in Tibetan and Andean populations using dense genome scan data.. PLoS genetics, (9): [PMID:20838600] |
| 41. Flashman, Emily E and 5 more authors.. (2010) Evidence for the slow reaction of hypoxia-inducible factor prolyl hydroxylase 2 with oxygen.. The FEBS journal, [PMID:20840591] |
| 42. Chowdhury, Rasheduzzaman R and 9 more authors.. (2011) Studies on the reaction of nitric oxide with the hypoxia-inducible factor prolyl hydroxylase domain 2 (EGLN1).. Journal of molecular biology, (8): [PMID:21601578] |
| 43. Su, Yun Y and 7 more authors.. (2012) Prolyl hydroxylase-2 (PHD2) exerts tumor-suppressive activity in pancreatic cancer.. Cancer, (15): [PMID:21792862] |
| 44. Foxler, Daniel E DE and 13 more authors.. (2012) The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activity.. Nature cell biology, (29): [PMID:22286099] |
| 45. Van Damme, Petra P and 15 more authors.. (2012) N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.. Proceedings of the National Academy of Sciences of the United States of America, (31): [PMID:22814378] |
| 46. Zhou, Houjiang H and 6 more authors.. (2013) Toward a comprehensive characterization of a human cancer cell phosphoproteome.. Journal of proteome research, (4): [PMID:23186163] |
| 47. Seo, K-S KS and 14 more authors.. (2015) SIRT2 regulates tumour hypoxia response by promoting HIF-1α hydroxylation.. Oncogene, (12): [PMID:24681946] |
| 48. Song, Daisheng D and 7 more authors.. (2014) Defective Tibetan PHD2 binding to p23 links high altitude adaption to altered oxygen sensing.. The Journal of biological chemistry, (23): [PMID:24711448] |
| 49. Lorenzo, Felipe R FR and 22 more authors.. (2014) A genetic mechanism for Tibetan high-altitude adaptation.. Nature genetics, [PMID:25129147] |
| 50. Kumar, Parveen P, Gullberg, Urban U, Olsson, Inge I and Ajore, Ram R.. (2015) Myeloid translocation gene-16 co-repressor promotes degradation of hypoxia-inducible factor 1.. PloS one, [PMID:25974097] |
| 51. Tumber, Anthony A and 27 more authors.. (2017) Potent and Selective KDM5 Inhibitor Stops Cellular Demethylation of H3K4me3 at Transcription Start Sites and Proliferation of MM1S Myeloma Cells.. Cell chemical biology, (16): [PMID:28262558] |
| 52. and Smirnoff, Nicholas.. (2018) Ascorbic acid metabolism and functions: A comparison of plants and mammals.. Free radical biology & medicine, [PMID:29567393] |